Novartis signs third ADC licensing agreement with Immunogen this year
Novartis has signed a third license agreement this year for a specific antigen target using Immunogen’s antibody-drug conjugate (ADC) technology.
Archives for November 29, 2013
Genetically engineered rice proves to produce high yields of rotavirus-specific antibody
Researchers recently genetically engineered rice to produce high yields of an antibody that proved effective in a study to treat and prevent rotavirus-induced gastrointestinal symptoms in mice.